Skip to content
Tenfell
Awarded contract
Published 24 Jul 2025

NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025

NHS England · London

Key facts

Awarded
24 Jun 2025
Procedure
Open procedure (framework)
Buyer type
Central government

Awarded to 28 suppliers

SupplierValue
Roche Products Ltd—
Amgen Ltd—
Biogen—
Teva UK Ltd—
Dr Reddy's Laboratories (UK) Ltd—
Orifarm UK—
Pfizer Ltd—
Vifor Pharma UK Limited—
Accord-UK Ltd—
Sandoz Ltd—
Eli Lilly & Company Ltd—
Chugai Pharma Uk Ltd—
Mylan—
Aventis Pharma Ltd T/A Sanofi—
Manx Healthcare Ltd—
Janssen-Cilag Ltd—
Novo Nordisk—
Sun Pharma UK Ltd—
Merck Serono Limited—
Bayer plc—
Napp Pharmaceuticals—
AstraZeneca—
CST Pharma Ltd—
Pharmacosmos UK Ltd—
Thornton & Ross Ltd—
GlaxoSmithKline—
Gedeon Richter UK Ltd—
Seqirus UK Limited—

Description

NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines – Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027 CM/PHR/24/5718/02 - NHS Framework Agreement for Branded Medicines – Adult Influenza (National). Period of Framework Agreement: 01 September 2025 to 31 August 2026

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.